Adverse symptomatology and suicide associated with the use of methylenedioxymethamphetamine (MDMA; ''ecstasy'')

被引：28
|
作者：
Cohen, RS
机构：
[1] Research Department, Peapack, NJ
[2] Research Department, Peapack, NJ 07977
来源：
BIOLOGICAL PSYCHIATRY | 1996年 / 39卷 / 09期
关键词：
ecstasy; MDMA; drug use; serotonin; suicide;
D O I：
10.1016/0006-3223(95)00551-X
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
[No abstract available]
引用
收藏
页码：819 / 820
页数：2
相关论文
共 50 条
  • [41] A profile of ecstasy (MDMA) use in Sao Paulo, Brazil: An ethnographic study
    Battisti, MC
    Noto, AR
    Nappo, S
    Carlini, ED
    JOURNAL OF PSYCHOACTIVE DRUGS, 2006, 38 (01) : 13 - 18
  • [42] Demographic and health characteristics of 3,4-methylenedioxymethamphetamine users (MDMA, ecstasy)
    Wieckiewicz, Gniewko
    Danel, Dariusz
    Piegza, Magdalena
    Gorczyca, Piotr
    Pudlo, Robert
    PSYCHIATRIA POLSKA, 2022, 56 (05) : 1109 - 1130
  • [43] Prevalence and Correlates of Past Year Ecstasy/MDMA Use in the United States
    Yang, Kevin H.
    Kepner, Wayne
    Nijum, Anamika
    Han, Benjamin H.
    Palamar, Joseph J.
    JOURNAL OF ADDICTION MEDICINE, 2023, 17 (05) : 592 - 597
  • [44] Methylenedioxymethamphetamine (MDMA, 'ecstasy') serves as a robust positive reinforcer in a rat runway procedure
    Wakionigg, G
    Strum, K
    Saria, A
    Zernig, G
    PHARMACOLOGY, 2003, 69 (04) : 180 - 182
  • [45] Fatal Diabetic Ketoacidosis-A Potential Complication of MDMA (Ecstasy) Use
    Gilbert, John D.
    Byard, Roger W.
    JOURNAL OF FORENSIC SCIENCES, 2018, 63 (03) : 939 - 941
  • [46] Lifetime use of MDMA/ecstasy and psilocybin is associated with reduced odds of major depressive episodes
    Jones, Grant M.
    Nock, Matthew K.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2022, 36 (01) : 57 - 65
  • [47] (±)-3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') increases social interaction in rats
    Morley, KC
    McGregor, IS
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 408 (01) : 41 - 49
  • [48] MDMA (Ecstasy) use and psychiatric problems
    Casey R. Guillot
    Mitchell E. Berman
    Psychopharmacology, 2007, 189 : 575 - 576
  • [49] Pharmacological aspects of the combined use of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and gamma-hydroxybutyric acid (GHB): a review of the literature
    Uys, JDK
    Niesink, RJM
    DRUG AND ALCOHOL REVIEW, 2005, 24 (04) : 359 - 368
  • [50] The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview
    Gouzoulis-Mayfrank, E
    Daumann, J
    JOURNAL OF PSYCHOPHARMACOLOGY, 2006, 20 (02) : 188 - 193
12345